Clinical TrialsSearch results
Number of results: 482
Other
- A feasibility study of accelerated partial breast irradiation using interstitial brachytherapy for female breast cancer <=3cm pN0M0
- breast cancer
- Oguchi Group, Grant for Cancer Research, Ministry of Health, Labour, and Welfare
- 2009-02-01
Other
- Phase2 Study of Glivec (imatinib mesylate, formerly known as STI571) in Patients with Relapsed or Refractory Sarcomas with c-kit or PDGFR Expression
- Sarcoma with c-kit or PDGFR expression by immunohistochemistry
- Office of Imatinib phase2 study
- 2005-08-22
Other
- Clinical Assessment to Establish the Symptomatic Advantage of Rabeprazole: double-blind, randomized, placebo-controlled study in functional dyspepsia
- Functional Dyspepsia
- Office of CAESAR study
- 2008-04-29
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31
Completed
- Therapeutic apps for control drinking or abstinence: A feasibility randomized controlled study
- alcohol dependence
- NOUSO Kazuhiro
- 2021-05-25
Other
- The changes of QOL in patients with Alzherimer's disease through medical treatment: an observational study
- Alzheimer's disease
- Non Profit Organization Institute of Community Medicine and Welfare for Central Nervous System
- 2008-07-19
Recruiting
- Research on remote exercise support for esophageal cancer patients
- Esophageal cancer
- Noma Tomohiro
- 2022-08-20
Other
- Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- untreated stage IV or relapsed/refractory NK/T-cell lymphoma
- NK-cell Tumor Study Group
- 2007-06-18
Other
- Phase II study of SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- extranodal NK/T-cell lymphoma, nasal type
- NK-cell Tumor Study Group
- 2007-05-14
Recruiting
- Phase II Trial of LP-300 in Combination with Carboplatin and Pemetrexed in Never Smoker Patients with Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment with Tyrosine Kinase Inhibitors
- Relapsed Advanced Primary Adenocarcinoma
- Nishioka Tsuyoshi
- 2024-06-14